• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类和非人灵长类疟疾中AMA-1分子家族的免疫方面。

Aspects of immunity for the AMA-1 family of molecules in humans and non-human primates malarias.

作者信息

Thomas A W, Narum D, Waters A P, Trape J F, Rogier C, Gonçalves A, Rosario V, Druilhe P, Mitchell G H, Dennis D

机构信息

Laboratory for Parasitology, BPRC-TNO, Rijswijk, The Netherlands.

出版信息

Mem Inst Oswaldo Cruz. 1994;89 Suppl 2:67-70. doi: 10.1590/s0074-02761994000600016.

DOI:10.1590/s0074-02761994000600016
PMID:7565135
Abstract

The apical membrane antigen (AMA-1) family of malaria merozoite proteins is characterised by a high degree of inter-species conservation. Evidence that the protein (PK66/AMA-1) from the simian parasite Plasmodium knowlesi was protective in rhesus monkeys suggested that the 83kDa P. falciparum equivalent (PF83/AMA-1) should be investigated for protective effects in humans. Here we briefly review pertinent comparative data, and describe the use of an eukaryotic full length recombinant PF83/AMA-1 molecule to develop a sensitive ELISA for the determination of serological responses in endemic populations. The assay has revealed surprisingly high levels of humoral response to this quantitatively minor antigen. We also show that PK66/AMA-1 inhibitory mAb's are active against merozoites subsequent to release from schizont-infected red cells, further implicating AMA-1 molecules in red cell invasion.

摘要

疟原虫裂殖子的顶端膜抗原(AMA-1)家族的特点是种间高度保守。来自猴疟原虫诺氏疟原虫的蛋白质(PK66/AMA-1)在恒河猴中具有保护作用,这一证据表明,应研究疟原虫83kDa的等效物(PF83/AMA-1)对人类的保护作用。在此,我们简要回顾相关的比较数据,并描述使用真核全长重组PF83/AMA-1分子开发一种灵敏的ELISA方法,以测定流行地区人群的血清学反应。该检测方法揭示了针对这种定量上较少的抗原令人惊讶的高水平体液反应。我们还表明,PK66/AMA-1抑制性单克隆抗体在裂殖体感染的红细胞释放裂殖子后对裂殖子具有活性,这进一步表明AMA-1分子参与红细胞入侵。

相似文献

1
Aspects of immunity for the AMA-1 family of molecules in humans and non-human primates malarias.人类和非人灵长类疟疾中AMA-1分子家族的免疫方面。
Mem Inst Oswaldo Cruz. 1994;89 Suppl 2:67-70. doi: 10.1590/s0074-02761994000600016.
2
Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites.恶性疟原虫裂殖子顶端膜抗原PF83/AMA-1全长形式和加工形式的差异定位
Mol Biochem Parasitol. 1994 Sep;67(1):59-68. doi: 10.1016/0166-6851(94)90096-5.
3
High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1.使用全长杆状病毒重组恶性疟原虫83千道尔顿顶端膜抗原(PF83/AMA-1)通过捕获酶联免疫吸附测定法检测到针对该抗原的天然抗体的高流行率。
Am J Trop Med Hyg. 1994 Dec;51(6):730-40. doi: 10.4269/ajtmh.1994.51.730.
4
Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. falciparum AMA-1, and antibody-mediated inhibition of red cell invasion.赖氏疟原虫顶端膜抗原-1(AMA-1)的分子特征、与恶性疟原虫AMA-1的比较以及抗体介导的红细胞入侵抑制
Mol Biochem Parasitol. 2000 Jul;109(2):147-56. doi: 10.1016/s0166-6851(00)00250-4.
5
Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.顶端膜抗原1是一种主要的疟疾疫苗候选物,它介导侵入性裂殖子与宿主红细胞的紧密附着。
Infect Immun. 2004 Jan;72(1):154-8. doi: 10.1128/IAI.72.1.154-158.2004.
6
Precise timing of expression of a Plasmodium falciparum-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization.恶性疟原虫衍生的转基因在伯氏疟原虫中表达的精确时间是随后亚细胞定位的关键决定因素。
J Biol Chem. 1998 Jun 12;273(24):15119-24. doi: 10.1074/jbc.273.24.15119.
7
Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum.针对恶性疟原虫顶膜抗原1的入侵抑制性抗体的作用模式
Infect Immun. 2005 Apr;73(4):2116-22. doi: 10.1128/IAI.73.4.2116-2122.2005.
8
Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites.入侵抑制性抗体可抑制恶性疟原虫裂殖子顶端膜抗原1的蛋白水解加工。
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12295-300. doi: 10.1073/pnas.2032858100. Epub 2003 Oct 2.
9
Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.恶性疟原虫 MSP3 存在于裂殖子表面的复合物上,并在自然感染过程中产生抗体反应。
Infect Immun. 2018 Jul 23;86(8). doi: 10.1128/IAI.00067-18. Print 2018 Aug.
10
Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.一种重组疟疾候选疫苗(恶性疟原虫AMA-1胞外结构域的I+II结构域,来自印度恶性疟原虫等位基因)的免疫原性。
Vaccine. 2008 Aug 18;26(35):4526-35. doi: 10.1016/j.vaccine.2008.06.031. Epub 2008 Jun 30.

引用本文的文献

1
Proteomic Identification and Functional Analysis of Reveals Heparin-Binding Proteins.蛋白质组学鉴定及功能分析揭示肝素结合蛋白
J Trop Med. 2025 Jan 11;2025:8821002. doi: 10.1155/jotm/8821002. eCollection 2025.
2
Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination.微阵列分析揭示了自然感染和接种疫苗后,针对恶性疟原虫顶膜抗原 1 变异体的菌株特异性抗体反应。
Sci Rep. 2020 Mar 3;10(1):3952. doi: 10.1038/s41598-020-60551-z.
3
Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1.
鉴定一种针对恶性疟原虫顶膜抗原 1 的新型人源单克隆抗体的抑制特性。
Sci Rep. 2016 Dec 21;6:39462. doi: 10.1038/srep39462.
4
Cytokine gene polymorphisms are not associated with anti-PvDBP, anti-PvAMA-1 or anti-PvMSP-119 IgG antibody levels in a malaria-endemic area of the Brazilian Amazon.在巴西亚马逊疟疾流行地区,细胞因子基因多态性与抗恶性疟原虫二磷酸果糖醛缩酶(anti-PvDBP)、抗恶性疟原虫裂殖子表面蛋白1(anti-PvAMA-1)或抗恶性疟原虫裂殖子表面蛋白119(anti-PvMSP-119)IgG抗体水平无关。
Malar J. 2016 Jul 19;15(1):374. doi: 10.1186/s12936-016-1414-3.
5
Plasmodium knowlesi gene expression differs in ex vivo compared to in vitro blood-stage cultures.诺氏疟原虫基因表达在体外血液阶段培养与体内培养中存在差异。
Malar J. 2015 Mar 13;14:110. doi: 10.1186/s12936-015-0612-8.
6
Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax.编码间日疟原虫候选疫苗抗原基因的遗传多样性和种群结构。
Malar J. 2012 Mar 14;11:68. doi: 10.1186/1475-2875-11-68.
7
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component.腺病毒 5 型载体疟疾疫苗表达 CSP 和 AMA1。B 部分:CSP 成分的安全性、免疫原性和保护效力。
PLoS One. 2011;6(10):e25868. doi: 10.1371/journal.pone.0025868. Epub 2011 Oct 7.
8
Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.一种单一蛋白质的疟疾疫苗相关益处,该蛋白质由恶性疟原虫顶端膜抗原1的结构域I和II与裂殖子表面蛋白1的19千道尔顿C末端片段的修饰形式融合而成。
Infect Immun. 2007 Dec;75(12):5947-55. doi: 10.1128/IAI.01804-06. Epub 2007 Oct 15.
9
posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.恶性疟原虫顶端膜抗原1的翻译后修饰:对疟疾候选疫苗功能性免疫反应的影响
Infect Immun. 2005 Jul;73(7):3963-70. doi: 10.1128/IAI.73.7.3963-3970.2005.
10
Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.顶端膜抗原1是一种主要的疟疾疫苗候选物,它介导侵入性裂殖子与宿主红细胞的紧密附着。
Infect Immun. 2004 Jan;72(1):154-8. doi: 10.1128/IAI.72.1.154-158.2004.